Ming-ching Q. Shen

No.1, Changde Street
Zhongzheng District, TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Non-Inversion Variants in Sporadic Hemophilia A Rarely Recur.

Non-Inversion Variants in Sporadic Hemophilia A Rarely Recur.

Journal: International journal of molecular sciences

Published: February 10, 2026

Genotype-Specific Postural Control Deficits in Hemophilia A: Insights from Center of Pressure Analysis Beyond Radiographic Arthropathy.

Genotype-Specific Postural Control Deficits in Hemophilia A: Insights from Center of Pressure Analysis Beyond Radiographic Arthropathy.

Journal: International journal of molecular sciences

Published: January 19, 2026

NXTAGE: a phase 1/2 study of NXT007 to assess safety, pharmacokinetics, and efficacy in hemophilia A without inhibitors.

NXTAGE: a phase 1/2 study of NXT007 to assess safety, pharmacokinetics, and efficacy in hemophilia A without inhibitors.

Journal: Blood

Published: September 30, 2025

Heterogeneous Hemostatic Disorder Associated with IgA Monoclonal Gammopathy: A Case Series.

Heterogeneous Hemostatic Disorder Associated with IgA Monoclonal Gammopathy: A Case Series.

Journal: Endocrine, metabolic & immune disorders drug targets

Published: April 30, 2025

Developmental Changes in Haemophilic Knee Joint Morphology: A Geometric Morphometric Study.

Developmental Changes in Haemophilic Knee Joint Morphology: A Geometric Morphometric Study.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: February 06, 2025

Noninversion Variants in Sporadic Hemophilia A Originate Mostly from Females.

Noninversion Variants in Sporadic Hemophilia A Originate Mostly from Females.

Journal: International journal of molecular sciences

Published: December 13, 2024

Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study.

Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study.

Journal: Blood

Published: October 07, 2024

Congenital Factor XIII Deficiency in Taiwan: A Novel F13A1 p.Lys113* Variant Identified in a Patient With an Inhibitor and Our Experience to Induce Immune Tolerance.

Congenital Factor XIII Deficiency in Taiwan: A Novel F13A1 p.Lys113* Variant Identified in a Patient With an Inhibitor and Our Experience to Induce Immune Tolerance.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: September 13, 2024

Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study.

Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study.

Journal: Drugs - real world outcomes

Published: August 25, 2024

Safety and efficacy of valoctocogene roxaparvovec with prophylactic glucocorticoids: 1-year results from the phase 3b, single-arm, open-label GENEr8-3 study.

Safety and efficacy of valoctocogene roxaparvovec with prophylactic glucocorticoids: 1-year results from the phase 3b, single-arm, open-label GENEr8-3 study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: March 25, 2024

Inherited coagulation factor VII deficiency in Taiwan: Two novel F7 variants with relevant regional features in 33 patients.

Inherited coagulation factor VII deficiency in Taiwan: Two novel F7 variants with relevant regional features in 33 patients.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: November 22, 2023

De Novo Noninversion Variants Implicated in Sporadic Hemophilia A: A Variant Origin and Timing Study.

De Novo Noninversion Variants Implicated in Sporadic Hemophilia A: A Variant Origin and Timing Study.

Journal: International journal of molecular sciences

Published: November 15, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026